All articles by Vidya Sagar Maddela
Vidya Sagar Maddela
J&J launches TECNIS Odyssey lens in Europe, Middle East, Canada
The TECNIS Odyssey IOL, designed based on the company’s TECNIS platform, promises enhanced vision quality for cataract patients, offering precise vision across all distances and lighting conditions.
Philips launches Flash 5100 POC to advance point-of-care ultrasound
The Flash 5100 POC system is designed based on Philips’ established cardiology and general imaging technology to address the needs of anaesthesia, critical care, emergency medicine, and musculoskeletal imaging.
Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
More than 26 million people worldwide have HF, and the majority have HFpEF, making it the largest unmet clinical need in cardiovascular medicine.
Mindray North America Breaks Ground on Major Warehouse Expansion Project in Mahwah, NJ
The Expansion Will Support Long-Term Growth and Operational Efficiency, Underscoring the Company’s Commitment to Better Serve Healthcare Providers
Abbott gets Health Canada approval for i-STAT TBI test cartridge
The test is performed on Abbott’s portable i-STAT Alinity instrument, which provides lab-quality results within 15 minutes and facilitates rapid evaluation of mild traumatic brain injuries (mTBI) at the patient’s bedside.
AiMIFY software receives CE mark for enhanced MRI in Europe
The software leverages advanced AI technology to enhance the contrast in brain MRI scans, achieving up to twice the contrast level typically obtained with standard gadolinium-based contrast agents (GBCAs).
InspireMD secures CE Mark for CGuard Prime to prevent stroke
The CGuard Prime is designed to prevent strokes by optimising the deliverability and deployment of the CGuard stent and incorporates user feedback and leverages the unique MicroNet mesh technology.
Qiagen, Incyte collaborate on companion diagnostic panel for blood cancers
Qiagen will develop a multimodal panel to detect gene alterations in haematological malignancies and will be validated on the Illumina NextSeq 550Dx platform, part of Qiagen’s collaboration with Illumina
Aortyx raises €13.8m to advance bioresorbable vascular patch
Aortyx intends to use the financing to achieve first-in-human readiness for its bioresorbable vascular patch, designed to treat aortic tears, thereby bringing the product closer to market.
Viz.ai obtains FDA approval for AI subdural measurement tool
Viz Subdural Plus offers comprehensive quantification of subdural haemorrhages (SDH) on non-contrast computed tomography (NCCT) images, enhancing the precision and reliability of clinical decision-making.